{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:33:55Z","timestamp":1793338435319,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ejps.2024.106882","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T06:39:02Z","timestamp":1724913542000},"page":"106882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Population pharmacokinetics of cyclosporine A in hematopoietic stem cell transplant recipients: A systematic review"],"prefix":"10.1016","volume":"204","author":[{"given":"Yunyun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2024.106882_bib0042","doi-asserted-by":"crossref","unstructured":"F. Akhlaghi, A.K. Trull, Distribution of cyclosporin in organ transplant recipients, Clin. Pharmacokinet. 41 (2002) 615\u2013637. https:\/\/doi.org\/10.2165\/00003088-200241090-00001. M.B. Pepys, G.M. Hirschfield, C-reactive protein: a critical update, J. Clin. Invest. 111 (2003) 805\u20131812. https:\/\/doi.org\/10.1172\/jci18921.","DOI":"10.2165\/00003088-200241090-00001"},{"key":"10.1016\/j.ejps.2024.106882_bib0004","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00228-018-2434-4","article-title":"Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals","volume":"74","author":"Atiq","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106882_bib0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.bmt.1705788","article-title":"(CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation","volume":"40","author":"Barkholt","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ejps.2024.106882_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/976793","article-title":"T-cell costimulatory molecules in acute-graft-versus host disease: therapeutic implications","volume":"2011","author":"Briones","year":"2011","journal-title":"Bone Marrow Res"},{"key":"10.1016\/j.ejps.2024.106882_bib0034","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1399-0012.1998.tb01098.x","article-title":"Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy","volume":"12","author":"Cantarovich","year":"1998","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.ejps.2024.106882_bib0031","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3892\/etm.2020.8732","article-title":"Initial dosage optimization of ciclosporin in pediatric Chinese patients who underwent bone marrow transplants based on population pharmacokinetics","volume":"20","author":"Chen","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejps.2024.106882_bib0013","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/FTD.0b013e31818a2a60","article-title":"CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients","volume":"30","author":"Crettol","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2024.106882_bib0002","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood-2014-08-597245","article-title":"Impaired thymic expression of tissue-restricted antigens licenses the de novo generation of autoreactive CD4+ T cells in acute GVHD","volume":"23","author":"Dertschnig","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ejps.2024.106882_bib0006","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/pharmaceutics13030360","article-title":"Cyclosporine lipid nanocapsules as thermoresponsive gel for dry eye management: promising corneal mucoadhesion, biodistribution and preclinical efficacy in rabbits","volume":"13","author":"Eldesouky","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2024.106882_bib0024","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00228-012-1275-9","article-title":"Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient","volume":"68","author":"Eljebari","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106882_bib0011","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2165\/00003088-199324060-00004","article-title":"Cyclosporin clinical pharmacokinetics","volume":"24","author":"Fahr","year":"1993","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2024.106882_bib0005","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2125.2007.03003.x","article-title":"Developmental pharmacokinetics of ciclosporin\u2013a population pharmacokinetic study in paediatric renal transplant candidates","volume":"64","author":"Fanta","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106882_bib0020","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00228-014-1728-4","article-title":"Population pharmacogenetic pharmacokinetic modeling for flip-flop phenomenon of enteric-coated mycophenolate sodium in kidney transplant recipients","volume":"70","author":"Han","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106882_bib0041","first-page":"2791","article-title":"Steady-state pharmacokinetics of cyclosporine in renal transplant patients: does an influence of age or body weight exist","volume":"26","author":"Humbert","year":"1994","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejps.2024.106882_bib0037","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1083-8791(03)00076-4","article-title":"Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation","volume":"9","author":"Jacobson","year":"2003","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ejps.2024.106882_bib0035","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.healun.2003.05.002","article-title":"Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral)","volume":"24","author":"Jaksch","year":"2005","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.ejps.2024.106882_bib0016","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40262-013-0114-1","article-title":"Reporting a population pharmacokinetic-pharmacodynamic study: a journal's perspective","volume":"53","author":"Jamsen","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2024.106882_bib0017","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40262-015-0236-8","article-title":"Reporting guidelines for clinical pharmacokinetic studies: the ClinPK statement","volume":"54","author":"Kanji","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2024.106882_bib0019","doi-asserted-by":"crossref","unstructured":"A.S. Kesselheim, The backlash against bioequivalence and the interchangeability of brand-name and generic drugs. CMAJ 183 (2011) 1350\u20131351. https:\/\/doi.org\/10.1503%2Fcmaj.110808.","DOI":"10.1503\/cmaj.110808"},{"key":"10.1016\/j.ejps.2024.106882_bib0028","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/1060028015577798","article-title":"Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphisms","volume":"49","author":"Kim","year":"2015","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejps.2024.106882_bib0012","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000139380","article-title":"Drug interactions and interindividual variability of ciclosporin metabolism in the small intestine","volume":"52","author":"Lampen","year":"1996","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejps.2024.106882_bib0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.2042-7158.1987.tb03436.x","article-title":"Cyclosporin: measurement of fraction unbound in plasma","volume":"39","author":"Legg","year":"1987","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106882_bib0029","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/s41401-019-0277-x","article-title":"Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation","volume":"40","author":"Li","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejps.2024.106882_bib0032","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/jcpt.13569","article-title":"Population pharmacokinetics of ciclosporin in allogeneic hematopoietic stem cell transplant recipients: c-reactive protein as a novel covariate for clearance","volume":"47","author":"Ling","year":"2022","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ejps.2024.106882_bib0009","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0091270012440281","article-title":"Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 1: volume of distribution at steady state","volume":"53","author":"Lombardo","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106882_bib0036","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007890-199907150-00011","article-title":"Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation","volume":"68","author":"Mahalati","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.ejps.2024.106882_bib0001","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1038\/s41598-018-24060-4","article-title":"In-patient outcomes of hematopoietic stem cell transplantation in patients with immune mediated inflammatory diseases: a nationwide study","volume":"8","author":"Mehta","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2024.106882_bib0040","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/j.1552-4604.1996.tb04221.x","article-title":"Pharmacokinetics of cyclosporine after renal transplant in children","volume":"36","author":"Mochon","year":"1996","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106882_bib0014","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/00007691-199512000-00017","article-title":"Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel","volume":"17","author":"Oellerich","year":"1995","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2024.106882_bib0026","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1742-4682-11-39","article-title":"Bayesian approach for the estimation of cyclosporine area under the curve using limited sampling strategies in pediatric hematopoietic stem cell transplantation, Theor","volume":"11","author":"Sarem","year":"2014","journal-title":"Biol. Med. Model"},{"key":"10.1016\/j.ejps.2024.106882_bib0022","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1399-3046.2008.00968.x","article-title":"Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough","volume":"13","author":"Schrauder","year":"2009","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ejps.2024.106882_bib0039","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0041-1345(98)00385-6","article-title":"The pharmacokinetics of oral cyclosporin A (Neoral) during the first month after bone marrow transplantation","volume":"30","author":"Schultz","year":"1998","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejps.2024.106882_bib0038","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.bmt.1702545","article-title":"Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation","volume":"26","author":"Schultz","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ejps.2024.106882_bib0007","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00007890-199802150-00003","article-title":"In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine","volume":"65","author":"Shin","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.ejps.2024.106882_bib0008","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0002-9440(10)62984-7","article-title":"Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition","volume":"167","author":"Slattery","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejps.2024.106882_bib0018","article-title":"Rockville: united States Department of Health and Human Services","year":"2001","journal-title":"US FDA, United States Center for Drug Evaluation and Research"},{"key":"10.1016\/j.ejps.2024.106882_bib0023","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1365-2125.2011.04116.x","article-title":"Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy","volume":"73","author":"Wilhelm","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106882_bib0021","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2125.2008.03217.x","article-title":"Ciclosporin kinetics in children after stem cell transplantation","volume":"66","author":"Willemze","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106882_bib0033","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/bcp.12394","article-title":"Pharmacokinetic tools for the dose adjustment of ciclosporin in haematopoietic stem cell transplant patients","volume":"78","author":"Woillard","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106882_bib0027","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MAJ.0000000000000337","article-title":"Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients","volume":"348","author":"Xue","year":"2014","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.ejps.2024.106882_bib0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11095-019-2740-2","article-title":"Multicenter-based population pharmacokinetic analysis of ciclosporin in hematopoietic stem cell transplantation patients","volume":"37","author":"Xue","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2024.106882_bib0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s13318-012-0087-8","article-title":"Population pharmacokinetics of cyclosporine A based on NONMEM in Chinese allogeneic hematopoietic stem cell transplantation recipients","volume":"37","author":"Zhou","year":"2012","journal-title":"Eur. J. Drug Metab. Pharmacokinet."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T19:34:01Z","timestamp":1738438441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724001945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":42,"alternative-id":["S0928098724001945"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106882","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetics of cyclosporine A in hematopoietic stem cell transplant recipients: A systematic review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106882"}}